Return to study ST001185 main page

Download data matrix(Genetic and metabolic characterization of bioengineered human fatty liver tissue with modified SIRT1 expression Reversed phase UNSPECIFIED ION MODE)

AnalysisSamplesFactorsUnits
Reversed phase UNSPECIFIED ION MODER1Source:Bioengineered human iPS-derived fatty liver tissue-iKD-SIRT1Peak area
Reversed phase UNSPECIFIED ION MODER2Source:Bioengineered human iPS-derived fatty liver tissue-iKD-SIRT1Peak area
Reversed phase UNSPECIFIED ION MODER3Source:Bioengineered human iPS-derived fatty liver tissue-iKD-SIRT1Peak area
Reversed phase UNSPECIFIED ION MODER4Source:Bioengineered human iPS-derived fatty liver tissue-iKD-SIRT1Peak area
Reversed phase UNSPECIFIED ION MODER5Source:Bioengineered human iPS-derived fatty liver tissue-iKD-SIRT1Peak area
Reversed phase UNSPECIFIED ION MODER6Source:Bioengineered human iPS-derived fatty liver tissue-iKD-SIRT1Peak area
Reversed phase UNSPECIFIED ION MODEN1Source:Healthy Control Liver TissuePeak area
Reversed phase UNSPECIFIED ION MODEN2Source:Healthy Control Liver TissuePeak area
Reversed phase UNSPECIFIED ION MODEN3Source:Healthy Control Liver TissuePeak area
Reversed phase UNSPECIFIED ION MODEF1Source:NASH Liver Tissue from PatientPeak area
Reversed phase UNSPECIFIED ION MODEF2Source:NASH Liver Tissue from PatientPeak area
Reversed phase UNSPECIFIED ION MODEF3Source:NASH Liver Tissue from PatientPeak area
  logo